Page last updated: 2024-10-26

ethosuximide and Lacrimal Apparatus Diseases

ethosuximide has been researched along with Lacrimal Apparatus Diseases in 1 studies

Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.

Lacrimal Apparatus Diseases: Diseases of the LACRIMAL APPARATUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lyons, C1
Godoy, F1
Vanden Driessche, K1

Other Studies

1 other study available for ethosuximide and Lacrimal Apparatus Diseases

ArticleYear
Bilateral subacute lacrimal gland enlargement mimicking dacryoadenitis in a 7-year-old boy: a rare adverse effect of valproic acid (sodium valproate).
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2017, Volume: 21, Issue:3

    Topics: Acute Disease; Anticonvulsants; Child; Dacryocystitis; Diagnosis, Differential; Drug Substitution; E

2017